Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03419195 · ClinicalTrials.gov registry record · NA
Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT03419195 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 124 participants.
The verdict
NCT03419195, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
This study will define the relationship of cardiac, vascular function and skeletal muscle blood flow (individually and together) to cardiovascular exercise capacity in in men and women with and without type 2 diabetes (T2DM). Identification of differences in the effects of exercise training on the integrated cardiovascular system and metabolism in men and women with and without T2DM will reveal specific adaptive responses to exercise.This study will evaluate \& compare exercise function in a total of 60 subjects from the Denver area (30 people with T2DM and 30 overweight control subjects). Specific Aim 1: To test the hypothesis that the integration of cardiac function, macrovascular function, and microvascular function is impaired in T2D and correlates with cardiovascular exercise capacity (CVEC) impairment. Specific Aim 2: To test the hypothesis that exercise training will elicit adaptive responses in cardiac and vascular function, muscle perfusion and metabolism with differences by T2D status. Differences between the exercise responses in people with T2DM and healthy people will help further identify the disease process of T2DM and direct future research of treatments and interventions.
Interventions
- OTHER Cardiovascular exercise training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2018-02-07 |
| Est. Completion | 2023-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03419195
The ClinicalTrials.gov registry entry for NCT03419195 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiovascular exercise training is the first listed.
NCT03419195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03419195 about?
NCT03419195 is a clinical study titled "Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex". This study will define the relationship of cardiac, vascular function and skeletal muscle blood flow (individually and together) to cardiovascular exercise capacity in in men and women with and without type 2 diabetes (T2DM). Identification of differences in the effects of exercise training on the i...
What is the current status of trial NCT03419195?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2018-02-07. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT03419195?
The interventions under investigation include: Cardiovascular exercise training (OTHER).
Who is sponsoring clinical trial NCT03419195?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.